Safety of using genetic engineering biological agents in rheumatoid arthritis
The paper reviews the current trials of the safety of using genetic engineering biological agents (GEBA) in patients with rheumatoid arthritis. It is stated that before its start, GEBA therapy calls for thorough screening of patients to rule out communicable diseases (including tuberculosis) or a hi...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Article |
| Langue: | russe |
| Publié: |
IMA-PRESS LLC
2010-03-01
|
| Collection: | Современная ревматология |
| Sujets: | |
| Accès en ligne: | https://mrj.ima-press.net/mrj/article/view/272 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|